Key result
Clinical presentation of venous thromboembolism and duration of anticoagulation affect the risk of recurrent events after anticoagulation is stopped.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Supports individualized anticoagulation cessation after VTE by presentation and duration; confirms these as recurrence risk determinants.
How does clinical presentation of venous thromboembolism (VTE) and duration of anticoagulation affect risk for recurrent VTE after anticoagulation is stopped? In this pooled analysis of data from seven randomized trials that involved 2925 participants, investigators addressed this question. Twenty percent of the patients had isolated distal deep venous thrombosis (DVT), 52% had …
No takes yet. Share an insight, caveat, or question.
Mueller et al. (2011) studied this question. Clinical presentation of venous thromboembolism and duration of anticoagulation affect the risk of recurrent events after anticoagulation is stopped.
Synapse has enriched 10 related papers. Consider them for comparative context: